Central nervous system involvement in adult T-cell leukemia/lymphoma
- PMID: 2295055
- DOI: 10.1002/1097-0142(19900115)65:2<327::aid-cncr2820650224>3.0.co;2-w
Central nervous system involvement in adult T-cell leukemia/lymphoma
Abstract
Central nervous system (CNS) involvement was reviewed in 99 patients with adult T-cell leukemia/lymphoma (ATLL). Fifteen episodes of CNS involvement developed in ten of 99 patients (10.1%); nine had leptomeningeal involvement, whereas two developed intracerebral invasion, one developed cord involvement, and one developed both. CNS involvement was more frequent in the lymphoma type than in the other types of ATLL. Nuchal rigidity was not common (33%) and a syndrome of inappropriate secretion of antidiuretic hormone (ADH) occurred in association with CNS involvement (40%). Three episodes of marked hypoglycorrhachia also were noticed. The systemic progression of ATLL was the most common setting of CNS involvement (80%) and the major cause of death (80%). As for the acute and lymphoma types of ATLL, no significant difference was observed in survival between patients with and those without CNS involvement. These results indicate that CNS involvement is not an essential prognostic factor of ATLL and that it should be treated with systemic chemotherapy coupled with intrathecal chemotherapy. The control of systemic ATLL is important for the prophylaxis of CNS involvement.
Similar articles
-
Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature.Int J Hematol. 2016 Sep;104(3):392-5. doi: 10.1007/s12185-016-2015-1. Epub 2016 May 4. Int J Hematol. 2016. PMID: 27145781
-
Central nervous system involvement in T-cell lymphoma: A single center experience.Acta Oncol. 2016 May;55(5):561-6. doi: 10.3109/0284186X.2015.1118656. Epub 2016 Apr 4. Acta Oncol. 2016. PMID: 27046135 Free PMC article.
-
Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.J Clin Oncol. 2011 Dec 10;29(35):4696-701. doi: 10.1200/JCO.2011.35.5578. Epub 2011 Oct 31. J Clin Oncol. 2011. PMID: 22042945
-
Clinicopathologic features of adult T-cell leukemias/lymphomas at a North American tertiary care medical center: infrequent involvement of the central nervous system.Am J Surg Pathol. 2014 Feb;38(2):245-56. doi: 10.1097/PAS.0000000000000109. Am J Surg Pathol. 2014. PMID: 24418858 Review.
-
Clinical and endoscopic features of adult T-cell leukemia/lymphoma with duodenal involvement.J Clin Gastroenterol. 2001 Sep;33(3):241-6. doi: 10.1097/00004836-200109000-00017. J Clin Gastroenterol. 2001. PMID: 11500618 Review.
Cited by
-
Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma.Case Rep Hematol. 2014;2014:917369. doi: 10.1155/2014/917369. Epub 2014 Dec 23. Case Rep Hematol. 2014. PMID: 25587470 Free PMC article.
-
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin Oncol. 2019 Mar 10;37(8):677-687. doi: 10.1200/JCO.18.00501. Epub 2019 Jan 18. J Clin Oncol. 2019. PMID: 30657736 Free PMC article.
-
Distinct characteristics and social determinants in adult T-cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada.Br J Haematol. 2025 Jul;207(1):132-140. doi: 10.1111/bjh.20132. Epub 2025 May 6. Br J Haematol. 2025. PMID: 40328512 Free PMC article.
-
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.PLoS One. 2018 Mar 14;13(3):e0191461. doi: 10.1371/journal.pone.0191461. eCollection 2018. PLoS One. 2018. PMID: 29538376 Free PMC article.
-
Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment.J Hematol. 2023 Feb;12(1):42-48. doi: 10.14740/jh1037. Epub 2023 Feb 25. J Hematol. 2023. PMID: 36895291 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials